Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01936662 · ClinicalTrials.gov registry record · NA
Endotracheal Tube Versus Laryngeal Mask Airway for Esophagogastroduodenoscopy
A NA study, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 84
- Enrollment target
NCT01936662 is a NA study that has completed, run by Indiana University. The registered enrollment target is 84 participants.
The verdict
NCT01936662, a NA study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 84 participants
- Enrollment target
Study Summary
Esophagogastroduodenoscopy (EGD) is a relatively common procedure in pediatric patients undergoing evaluation for various gastrointestinal ailments. The procedure itself, with or without associated biopsies, is relatively short in length. Unlike adults, who regularly undergo this procedure with conscious sedation, children most often require general anesthesia. While safe and effective, endotracheal tracheal tube (ETT) intubation of children for EGD can result in delayed awakening and slow room turnover, particularly when intravenous medications are required for intubation. Laryngeal mask airway (LMA) is an alternative to intubation, which permits removal before full awakening. Although considered a safe alternative to tracheal intubation in appropriate cases, disadvantages of the LMA have been reported including kinking, occluding view of the surgical field, failure of placement requiring tracheal intubation, aspiration of gastric contents, desaturation, and laryngospasm. The study was designed to determine whether use of an LMA for EGD could reduce operating room time, while providing satisfactory conditions for the endoscopist, and an equivalent side effect and safety profile as compared to ETT in otherwise healthy children with gastrointestinal complaints
Interventions
- DEVICE LMA
- DEVICE ETT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2011-08 |
| Est. Completion | 2013-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01936662
The ClinicalTrials.gov registry entry for NCT01936662 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which LMA is the first listed.
NCT01936662 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01936662 about?
NCT01936662 is a clinical study titled "Endotracheal Tube Versus Laryngeal Mask Airway for Esophagogastroduodenoscopy". Esophagogastroduodenoscopy (EGD) is a relatively common procedure in pediatric patients undergoing evaluation for various gastrointestinal ailments. The procedure itself, with or without associated biopsies, is relatively short in length. Unlike adults, who regularly undergo this procedure with cons...
What is the current status of trial NCT01936662?
This trial is currently completed. It is a NA study. The enrollment target is 84 participants. The study started on 2011-08. Estimated completion is 2013-02.
What interventions are being tested in trial NCT01936662?
The interventions under investigation include: LMA (DEVICE), ETT (DEVICE).
Who is sponsoring clinical trial NCT01936662?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.